Predict your next investment

Agendia company logo
HEALTHCARE | Biotechnology
agendia.com

See what CB Insights has to offer

Founded Year

2003

Stage

Unattributed | Alive

Total Raised

$163.8M

Last Raised

$35M | 3 yrs ago

About Agendia

Agendia is a privately held, leading molecular diagnostics company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia's breast cancer and colorectal cancer tests were developed using an unbiased gene selection by analyzing the complete human genome. Our offerings include the FDA-cleared MammaPrint FFPE as well as BluePrint, a molecular subtyping assay that provides deeper insight leading to more clinically actionable breast cancer biology, and TargetPrint, a breast cancer ER/PR/HER2 expression assay. These tests can help physicians assess a patient's individual risk for metastasis – that is, which patients are more sensitive to chemo, hormonal, or combination therapy, and which patients may not require these treatments and which patients may be treated with other, less arduous and costly methods.

Agendia Headquarter Location

Amsterdam, 1098 AX,

Netherlands

+31 (0)20 462 1500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Agendia

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Agendia in 2 CB Insights research briefs, most recently on Dec 16, 2020.

Expert Collections containing Agendia

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Agendia is included in 6 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

960 items

Startups focused on providing products and services catering to women's health and wellbeing.

M

Medical Devices

10,972 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Agendia Patents

Agendia has filed 11 patents.

The 3 most popular patent topics include:

  • Abdomen
  • Clusters of differentiation
  • DNA sequencing
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/28/2015

9/11/2018

Experimental cancer drugs, Transcription factors, Breast cancer, Monoclonal antibodies for tumors, Oncology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/28/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/11/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Experimental cancer drugs, Transcription factors, Breast cancer, Monoclonal antibodies for tumors, Oncology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Agendia Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Agendia Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.